Mirion Technologies Inc (MIR) FinancialsMIRMirion Technologies Inc

Mirion Technologies, Inc. (MIR) generates its revenue through a diversified portfolio of business segments. Currently, the largest contributor to its top-line growth is Nuclear, accounting for 36.7% of total sales, equivalent to $81.80M. Other significant revenue streams include Cancer care and Labs and research. Understanding this composition is critical for investors evaluating how MIR navigates market cycles within the Industrial Machinery & Equipment industry.

Evaluating the bottom line, Mirion Technologies, Inc. maintains a gross margin of 49.89%. This metric reflects the company's pricing power and manufacturing efficiency. Further down the income statement, the operating margin stands at 6.86%, while the net margin is 3.04%. These profitability ratios, combined with a Return on Equity (ROE) of 1.49%, provide a clear picture of how effectively MIR converts its operational activities into shareholder value.

In the context of the broader market, MIR competes directly with industry leaders such as AIR and BETA. With a market capitalization of $3.77B, it holds a significant position in the sector. When comparing efficiency, MIR's gross margin of 49.89% stands against AIR's 19.20% and BETA's 54.72%. Such benchmarking helps identify whether Mirion Technologies, Inc. is trading at a premium or discount relative to its financial performance.

Mirion has shown a consistent revenue increase, with Q2 2026 revenue at $266.8 million and a gross margin of 49.89%.